ediverse Explore the platform

Spotlight PEPPOL BIS Billing 3.0 The EU e-invoicing mandate is here — France Sept 2026, Belgium Jan 2026, Germany 2025.

RegulatedAuthorization

A regulatory authorisation: drug MA, device CE marking, facility accreditation. The FHIR envelope for regulatory decisions.

Purpose

RegulatedAuthorization wraps the regulatory decision that legalises a product: marketing authorisation (EMA, FDA, ANSM), device CE marking, HAS accreditation, clinical trial approvals. The resource carries the issuing authority, identifier, date, territorial scope and attached conditions.

Key elements

FieldTypeCardinalityRole
identifierIdentifier[]0..*Authorisation identifiers.
subjectReference(MedicinalProductDefinition | BiologicallyDerivedProduct | NutritionProduct | PackagedProductDefinition | Ingredient | SubstanceDefinition | DeviceDefinition | ResearchStudy | ActivityDefinition | PlanDefinition | ObservationDefinition | Practitioner | Organization)[]0..*Authorisation subject.
typeCodeableConcept0..1Authorisation type.
descriptionmarkdown0..1Description.
regionCodeableConcept[]0..*Covered territories.
statusCodeableConcept0..1Status.
statusDatedateTime0..1Status date.
validityPeriodPeriod0..1Validity period.
indicationCodeableReference[]0..*Authorised indications.
holderReference(Organization)0..1Holder.
regulatorReference(Organization)0..1Issuing authority.

JSON example

json regulatedauthorization-example.json
{
  "resourceType": "RegulatedAuthorization",
  "id": "example-amm-aspirin",
  "identifier": [{
    "system": "https://ansm.sante.fr/amm",
    "value": "AMM-2010-A-12345"
  }],
  "subject": [{
    "reference": "MedicinalProductDefinition/aspirin-300"
  }],
  "type": {
    "coding": [{
      "system": "http://hl7.org/fhir/regulated-authorization-type",
      "code": "MarketingAuth"
    }]
  },
  "region": [{
    "coding": [{
      "system": "urn:iso:std:iso:3166",
      "code": "FR"
    }]
  }],
  "status": {
    "coding": [{
      "system": "http://hl7.org/fhir/publication-status",
      "code": "active"
    }]
  },
  "statusDate": "2010-06-15",
  "validityPeriod": {
    "start": "2010-06-15"
  },
  "holder": {
    "reference": "Organization/bayer-fr"
  },
  "regulator": {
    "reference": "Organization/ansm"
  }
}

Common pitfalls

  • No region: 'world-wide' authorisation is suspicious, avoid.
  • Holder vs regulator confused: holder = MA holder, regulator = authority.
  • Type='MarketingAuth' used for a clinical trial: wrong code, prefer 'ClinicalTrialAuth'.